|
MTR expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.80295794855101E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.44193595636489E-12 |
| Normal-vs-Stage2 |
3.77380000000649E-05 |
| Normal-vs-Stage3 |
5.07690001150252E-10 |
| Normal-vs-Stage4 |
1.65969999998961E-06 |
| Stage1-vs-Stage2 |
4.274400E-01 |
| Stage1-vs-Stage3 |
3.822400E-01 |
| Stage1-vs-Stage4 |
9.030000E-01 |
| Stage2-vs-Stage3 |
2.203000E-01 |
| Stage2-vs-Stage4 |
6.241000E-01 |
| Stage3-vs-Stage4 |
5.047000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.86484202816473E-12 |
| Normal-vs-AfricanAmerican |
4.598200E-02 |
| Normal-vs-Asian |
5.18420000261699E-08 |
| Caucasian-vs-AfricanAmerican |
1.560410E-02 |
| Caucasian-vs-Asian |
7.696400E-01 |
| AfricanAmerican-vs-Asian |
2.018300E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.72100000098652E-08 |
| Normal-vs-Female |
2.51654252991784E-12 |
| Male-vs-Female |
2.360600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.09570027998041E-10 |
| Normal-vs-Age(41-60Yrs) |
6.90130175229342E-11 |
| Normal-vs-Age(61-80Yrs) |
4.92870000035062E-07 |
| Normal-vs-Age(81-100Yrs) |
2.156200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.150200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.504400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.982600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.806600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.314000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.073400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.247700E-04 |
| Classical-VS-Follicular |
9.653200E-01 |
| Classical-VS-Other |
3.578800E-01 |
| Classical-VS-Normal |
4.32329949617838E-10 |
| Tall-VS-Follicular |
5.200300E-03 |
| Tall-VS-Other |
6.222400E-01 |
| Tall-VS-Normal |
4.26110258189283E-11 |
| Follicular-VS-Other |
3.810600E-01 |
| Follicular-VS-Normal |
5.06160000024458E-07 |
| Other-VS-Normal |
2.098100E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.61250029889959E-10 |
| Normal-vs-N1 |
7.05129999944987E-08 |
| N0-vs-N1 |
5.268000E-01 |
|
|
